Johnson & Johnson (JNJ)

$177.40 -0.66 (-0.37%)
Market Cap 428.83B
Revenue (ttm) 88.82B
Net Income (ttm) 14.07B
EPS (ttm) N/A
PE Ratio 17.85
Forward PE 16.44
Profit Margin 15.84%
Debt to Equity Ratio 0.50
Volume 4,768,547
Avg Vol 8,283,214
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 72%
Beta 0.40
Analysts Sell
Price Target $178.27

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
mohernx
mohernx Sep. 15 at 11:58 PM
$JNJ Oh well, NVCR has the next generation lung cancer treatment, approved in Japan today. Will also get pancreatic cancer treatment. Once again JNJ is behind the eight ball. NVCR acquisition will be a lot cheaper than slow R&D process. Sad Mariposa was the jewel of the Nile. Kind of late though.
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 15 at 10:58 PM
$FBIO Updated link, more here: For more info on FIRST EVER TREATMENT for MENKES Disease, a Pediatric, often Fatal Condition, Pending Sept 30th PDUFA for $FBIO. And for latest Isotretinoin and Male Infertility Treatment studies, using Istotretinoin, AKA, ACCUTANE, which is owned by $DERM, a subsidiary of $FBIO, that can treat Male Infertility, based on recent studies. See link below and read quoted post below . https://x.com/ravagelaserbeak/status/1967719314229997659 Related tickers: $DERM $BIB $JNJ $MRK
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 15 at 8:31 PM
$FBIO + $DERM ($DERM is a subsidiary of $FBIO ) Aside from Sept 30th PDUFA = we have this = " For men with infertility caused by extremely low sperm counts or a complete lack of sperm, the only medical option is to undergo surgery to collect sperm directly from the testicles to then use for in vitro fertilization (IVF). But this is a significant surgery that involves discomfort; potential risks, such as infection; and a prolonged recovery period. Moreover, the surgery only yields sperm about half the time. Now, researchers are exploring an alternative: isotretinoin, better known as Accutane, a drug that has been used for decades to treat severe acne. In a small study published in July in the Journal of Assisted Reproduction and Genetics, the drug stimulated sperm production in some men who at baseline had no or very few sperm in their ejaculate. " Good Post on $FBIO More here = https://x.com/ravagelaserbeak/status/1967686200199889335?s=46 related tickers = $BIB $DERM $PFE $JNJ
0 · Reply
sister
sister Sep. 15 at 5:25 PM
$MRNA be just fine as this Kissing Disease News dribbles out . . . $JNJ $PFE
0 · Reply
Quantumup
Quantumup Sep. 15 at 5:21 PM
Guggenheim reiterated $ABVX at a Buy rating and $101 PT. [ #UEGWeek $LLY $JNJ - $PTGX] Guggenheim said:
0 · Reply
BillionerOfKing
BillionerOfKing Sep. 15 at 12:11 PM
$JNJ Current Stock Price: $178.08 Contracts to trade: $180 JNJ Sep 19 2025 Call Entry: $0.71 Exit: $1.01 ROI: 42% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Wallstreetbaggers
Wallstreetbaggers Sep. 15 at 11:00 AM
$JNJ could see the next leg up, needs to break resistance.
0 · Reply
GemsBot
GemsBot Sep. 13 at 2:40 PM
5 of 11 $HON $IBM $JNJ Dark green arrows indicate strong buy signals, while dark red arrows indicate strong sell signals. Lighter colored arrows are confirmation signals or signals to add, for large portfolios that use multiple entry points … see 6/11
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 13 at 12:20 PM
Enter: $JNJ OCT 03 2025 $180 CALLS Buy in Price: $1.96 - $2.11 Take Profit: $2.57 Stop Bleeding: $1.72 ROI Potential: 31% Exit Within: 37 Minutes https://moneygroup.us/alerts
0 · Reply
sister
sister Sep. 12 at 9:21 PM
$MRNA Adding on lies and manipulation for breakout towards $170.47 from 2 years ago . . . $PFE $JNJ
0 · Reply
Latest News on JNJ
Johnson & Johnson to showcase industry-leading neuropsychiatry innovations at the 2025 Psych Congress Annual Meeting

Sep 15, 2025, 8:00 AM EDT - 12 hours ago

Johnson & Johnson to showcase industry-leading neuropsychiatry innovations at the 2025 Psych Congress Annual Meeting

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

Sep 12, 2025, 1:37 PM EDT - 3 days ago

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

BNTX KVUE MRNA PFE

J&J Painting Recognized with 2026 Consumer Choice Award for Painting Contractor in Waterloo

Sep 12, 2025, 6:00 AM EDT - 3 days ago

J&J Painting Recognized with 2026 Consumer Choice Award for Painting Contractor in Waterloo

This year healthcare is the worst performing part of the market by far, says Jim Cramer

Sep 11, 2025, 8:18 PM EDT - 4 days ago

This year healthcare is the worst performing part of the market by far, says Jim Cramer

After a couple years in purgatory, Johnson & Johnson is now having a strong year, says Jim Cramer

Sep 11, 2025, 8:15 PM EDT - 4 days ago

After a couple years in purgatory, Johnson & Johnson is now having a strong year, says Jim Cramer

Johnson & Johnson seeks first European Medicines Agency approval for icotrokinra aiming to transform the plaque psoriasis treatment paradigm

Sep 11, 2025, 7:56 AM EDT - 4 days ago

Johnson & Johnson seeks first European Medicines Agency approval for icotrokinra aiming to transform the plaque psoriasis treatment paradigm

Johnson & Johnson (JNJ) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 10, 2025, 2:55 PM EDT - 5 days ago

Johnson & Johnson (JNJ) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Trump's Going After Prescription Drug Ads. What It Means for Pharmaceutical Sales.

Sep 10, 2025, 12:12 PM EDT - 5 days ago

Trump's Going After Prescription Drug Ads. What It Means for Pharmaceutical Sales.

LLY PFE

US FDA approves J&J's bladder cancer treatment

Sep 9, 2025, 4:28 PM EDT - 6 days ago

US FDA approves J&J's bladder cancer treatment

U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated

Sep 9, 2025, 4:18 PM EDT - 6 days ago

U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated

Johnson & Johnson: JNJ Stock To $250?

Sep 9, 2025, 10:20 AM EDT - 6 days ago

Johnson & Johnson: JNJ Stock To $250?

Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors

Sep 8, 2025, 6:17 PM EDT - 7 days ago

Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors

Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum

Sep 8, 2025, 4:25 PM EDT - 7 days ago

Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum

Johnson & Johnson: All-Time Highs In Sight After Raised Guidance And A Technical Breakout

Sep 8, 2025, 8:01 AM EDT - 7 days ago

Johnson & Johnson: All-Time Highs In Sight After Raised Guidance And A Technical Breakout

Johnson & Johnson: A Safe Hold, But Lacking Catalysts To Beat The Market

Sep 8, 2025, 4:05 AM EDT - 7 days ago

Johnson & Johnson: A Safe Hold, But Lacking Catalysts To Beat The Market

Data published in The New England Journal of Medicine demonstrate RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) is re-setting survival expectations in first-line EGFR-mutated lung cancer

Sep 7, 2025, 3:22 AM EDT - 8 days ago

Data published in The New England Journal of Medicine demonstrate RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) is re-setting survival expectations in first-line EGFR-mutated lung cancer

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer

Sep 6, 2025, 3:00 AM EDT - 9 days ago

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer

September Dogs Of The Dow Unleash One Ideal 'Safer' DiviDog

Sep 6, 2025, 2:07 AM EDT - 9 days ago

September Dogs Of The Dow Unleash One Ideal 'Safer' DiviDog

AMGN AMZN BA CRM CSCO CVX DIS

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

Sep 3, 2025, 4:29 PM EDT - 12 days ago

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

Johnson & Johnson (JNJ) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)

Sep 3, 2025, 2:42 PM EDT - 12 days ago

Johnson & Johnson (JNJ) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)

Global drugmakers rush to boost US presence as tariff threat looms

Sep 3, 2025, 2:09 PM EDT - 12 days ago

Global drugmakers rush to boost US presence as tariff threat looms

ABBV AMGN AZN BIIB GILD LLY MRK

Johnson & Johnson Unveils Results from the VARIPURE Substudy of SECURE, a Real-World Study on VARIPULSE™ Platform, at 2025 European Society of Cardiology (ESC) Congress

Sep 2, 2025, 8:00 AM EDT - 13 days ago

Johnson & Johnson Unveils Results from the VARIPURE Substudy of SECURE, a Real-World Study on VARIPULSE™ Platform, at 2025 European Society of Cardiology (ESC) Congress

New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump

Aug 31, 2025, 12:15 PM EDT - 15 days ago

New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump

J&J drops development of combination arthritis drug

Aug 28, 2025, 5:13 PM EDT - 18 days ago

J&J drops development of combination arthritis drug

Healthcare Stocks Are ‘Priced at Panic Levels.' It's Time to Buy.

Aug 28, 2025, 2:41 PM EDT - 18 days ago

Healthcare Stocks Are ‘Priced at Panic Levels.' It's Time to Buy.

ABBV LLY XLV

AMDR Applauds Federal Court Decision to Bar Johnson & Johnson's Biosense Webster Unit from Further Violation of Anti-Trust Laws in a Win for Hospitals, Patients, and the Environment

Aug 28, 2025, 8:00 AM EDT - 18 days ago

AMDR Applauds Federal Court Decision to Bar Johnson & Johnson's Biosense Webster Unit from Further Violation of Anti-Trust Laws in a Win for Hospitals, Patients, and the Environment

Best Dividend Aristocrats For September 2025

Aug 27, 2025, 2:09 PM EDT - 19 days ago

Best Dividend Aristocrats For September 2025

ABBV ABT ADM ADP AFL ALB AMCR

2 High-Conviction Picks For 7.73% Growth And 4.22% Yield Within A Dividend Portfolio

Aug 26, 2025, 3:00 PM EDT - 20 days ago

2 High-Conviction Picks For 7.73% Growth And 4.22% Yield Within A Dividend Portfolio

AAPL BLK META PEP

Best Dividend Kings: August 2025

Aug 24, 2025, 10:13 PM EDT - 21 days ago

Best Dividend Kings: August 2025

ABBV ABM ABT ADM AWR BDX BKH

Johnson & Johnson to invest $2B in North Carolina plant as Trump's 250% drug tariffs loom

Aug 22, 2025, 5:34 PM EDT - 24 days ago

Johnson & Johnson to invest $2B in North Carolina plant as Trump's 250% drug tariffs loom

A new pharma factory shows how hard it could be for drugmakers to outrun Trump's tariffs

Aug 21, 2025, 1:20 PM EDT - 25 days ago

A new pharma factory shows how hard it could be for drugmakers to outrun Trump's tariffs

REGN

Johnson & Johnson announces $2 billion investment to boost U.S. manufacturing as tariffs loom

Aug 21, 2025, 11:41 AM EDT - 25 days ago

Johnson & Johnson announces $2 billion investment to boost U.S. manufacturing as tariffs loom

Johnson & Johnson to invest $2 billion in North Carolina to boost US manufacturing

Aug 21, 2025, 5:11 AM EDT - 25 days ago

Johnson & Johnson to invest $2 billion in North Carolina to boost US manufacturing

Back To Basics: Why I Favor Amgen Over Johnson & Johnson

Aug 14, 2025, 3:06 PM EDT - 4 weeks ago

Back To Basics: Why I Favor Amgen Over Johnson & Johnson

AMGN

10 stocks with recently increased dividends — and why they merit a closer look

Aug 11, 2025, 4:29 PM EDT - 5 weeks ago

10 stocks with recently increased dividends — and why they merit a closer look

ADM CMCSA GIS MDT OZK PNC PRU

August Dogs Of The Dow Unleashed 19 'Safer' Dividend Buys

Aug 7, 2025, 12:23 PM EDT - 5 weeks ago

August Dogs Of The Dow Unleashed 19 'Safer' Dividend Buys

AMGN AMZN BA CRM CVX DIS HD

Why Johnson & Johnson Stock Still Has Room To Run

Aug 4, 2025, 5:12 PM EDT - 6 weeks ago

Why Johnson & Johnson Stock Still Has Room To Run

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8.5% (August 2025)

Aug 2, 2025, 8:01 AM EDT - 6 weeks ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8.5% (August 2025)

ADP AMH APH ARCC ASR AVGO BTI

Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges

Aug 1, 2025, 12:01 PM EDT - 6 weeks ago

Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges

ABBV AMGN AZN BMY GILD GSK LLY

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

Aug 1, 2025, 9:11 AM EDT - 6 weeks ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

BAX MDT

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

Aug 1, 2025, 8:31 AM EDT - 6 weeks ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ABT ALNY AMGN ARGX AZN BAX

President Trump demands drugmakers slash prices within 60 days

Aug 1, 2025, 6:54 AM EDT - 6 weeks ago

President Trump demands drugmakers slash prices within 60 days

ABBV ABT ALNY AMGN ARGX AZN BAX

Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says

Jul 31, 2025, 3:35 PM EDT - 6 weeks ago

Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says

ABBV AMGN AZN BMY GILD GSK LLY

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days.

Jul 31, 2025, 3:00 PM EDT - 6 weeks ago

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days.

ABBV AMGN AZN BMY GILD GSK LLY

Trump pressures 17 pharma CEOs to cut US drug prices

Jul 31, 2025, 2:28 PM EDT - 6 weeks ago

Trump pressures 17 pharma CEOs to cut US drug prices

ABBV AMGN AZN BMY GILD GSK LLY

Trump posts letters to 17 pharmaceutical companies about drug prices

Jul 31, 2025, 2:19 PM EDT - 6 weeks ago

Trump posts letters to 17 pharmaceutical companies about drug prices

ABBV GILD LLY PFE AMGN AZN BMY

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

Jul 31, 2025, 1:48 PM EDT - 6 weeks ago

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

ABBV AMGN AZN BMY GILD GSK LLY

Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Jul 30, 2025, 4:32 PM EDT - 6 weeks ago

Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case

Jul 29, 2025, 7:11 PM EDT - 6 weeks ago

Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case

Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions

Jul 29, 2025, 8:03 AM EDT - 6 weeks ago

Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions

mohernx
mohernx Sep. 15 at 11:58 PM
$JNJ Oh well, NVCR has the next generation lung cancer treatment, approved in Japan today. Will also get pancreatic cancer treatment. Once again JNJ is behind the eight ball. NVCR acquisition will be a lot cheaper than slow R&D process. Sad Mariposa was the jewel of the Nile. Kind of late though.
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 15 at 10:58 PM
$FBIO Updated link, more here: For more info on FIRST EVER TREATMENT for MENKES Disease, a Pediatric, often Fatal Condition, Pending Sept 30th PDUFA for $FBIO. And for latest Isotretinoin and Male Infertility Treatment studies, using Istotretinoin, AKA, ACCUTANE, which is owned by $DERM, a subsidiary of $FBIO, that can treat Male Infertility, based on recent studies. See link below and read quoted post below . https://x.com/ravagelaserbeak/status/1967719314229997659 Related tickers: $DERM $BIB $JNJ $MRK
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 15 at 8:31 PM
$FBIO + $DERM ($DERM is a subsidiary of $FBIO ) Aside from Sept 30th PDUFA = we have this = " For men with infertility caused by extremely low sperm counts or a complete lack of sperm, the only medical option is to undergo surgery to collect sperm directly from the testicles to then use for in vitro fertilization (IVF). But this is a significant surgery that involves discomfort; potential risks, such as infection; and a prolonged recovery period. Moreover, the surgery only yields sperm about half the time. Now, researchers are exploring an alternative: isotretinoin, better known as Accutane, a drug that has been used for decades to treat severe acne. In a small study published in July in the Journal of Assisted Reproduction and Genetics, the drug stimulated sperm production in some men who at baseline had no or very few sperm in their ejaculate. " Good Post on $FBIO More here = https://x.com/ravagelaserbeak/status/1967686200199889335?s=46 related tickers = $BIB $DERM $PFE $JNJ
0 · Reply
sister
sister Sep. 15 at 5:25 PM
$MRNA be just fine as this Kissing Disease News dribbles out . . . $JNJ $PFE
0 · Reply
Quantumup
Quantumup Sep. 15 at 5:21 PM
Guggenheim reiterated $ABVX at a Buy rating and $101 PT. [ #UEGWeek $LLY $JNJ - $PTGX] Guggenheim said:
0 · Reply
BillionerOfKing
BillionerOfKing Sep. 15 at 12:11 PM
$JNJ Current Stock Price: $178.08 Contracts to trade: $180 JNJ Sep 19 2025 Call Entry: $0.71 Exit: $1.01 ROI: 42% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Wallstreetbaggers
Wallstreetbaggers Sep. 15 at 11:00 AM
$JNJ could see the next leg up, needs to break resistance.
0 · Reply
GemsBot
GemsBot Sep. 13 at 2:40 PM
5 of 11 $HON $IBM $JNJ Dark green arrows indicate strong buy signals, while dark red arrows indicate strong sell signals. Lighter colored arrows are confirmation signals or signals to add, for large portfolios that use multiple entry points … see 6/11
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 13 at 12:20 PM
Enter: $JNJ OCT 03 2025 $180 CALLS Buy in Price: $1.96 - $2.11 Take Profit: $2.57 Stop Bleeding: $1.72 ROI Potential: 31% Exit Within: 37 Minutes https://moneygroup.us/alerts
0 · Reply
sister
sister Sep. 12 at 9:21 PM
$MRNA Adding on lies and manipulation for breakout towards $170.47 from 2 years ago . . . $PFE $JNJ
0 · Reply
TheGodofgreat
TheGodofgreat Sep. 12 at 5:09 PM
$XOM, $WMT, $PG, $JNJ
0 · Reply
Jack90
Jack90 Sep. 12 at 4:04 PM
$TSLA dumping EV, adding $BMY $JNJ $MRK $UNH not bad looking PE
0 · Reply
ZacksResearch
ZacksResearch Sep. 12 at 4:04 PM
$JNJ making moves in Europe 🚨 The company just filed for EMA approval of its oral psoriasis drug icotrokinra, targeting both adults and pediatric patients 12+. Full breakdown on the potential here 👉 https://www.zacks.com/stock/news/2750916/jnj-seeks-eu-approval-for-oral-psoriasis-drug-icotrokinra?cid=sm-stocktwits-2-2750916-teaser-12268&ADID=SYND_STOCKTWITS_TWEET_2_2750916_TEASER_12268
0 · Reply
sister
sister Sep. 12 at 3:56 PM
$MRNA adding here on manipulation for Fast Snapback to 30s . . . $JNJ $PFE
0 · Reply
ZacksResearch
ZacksResearch Sep. 12 at 3:04 PM
$JNJ's new psoriasis drug could reshape the market! 💊 📈 Icotrokinra shows strong efficacy & safety in Phase III trials 🌍 EMA filing also submitted in the U.S. in July 🔬 Potential game-changer in plaque psoriasis & other IL-23 diseases Discover JNJ's latest breakthrough here 👉 https://www.zacks.com/stock/news/2750916/jnj-seeks-eu-approval-for-oral-psoriasis-drug-icotrokinra?cid=sm-stocktwits-2-2750916-body-12234&ADID=SYND_STOCKTWITS_TWEET_2_2750916_BODY_12234
0 · Reply
SmartMoneySarge
SmartMoneySarge Sep. 12 at 5:51 AM
$JNJ $JPM $PLTR $SPX $SPY Entries and exits are EVERYTHING! 💰
1 · Reply
Andrestackz
Andrestackz Sep. 12 at 5:29 AM
$JNJ $JPM $PLTR $SPX $SPY
0 · Reply
PadZone1
PadZone1 Sep. 12 at 3:30 AM
Great Day Today team 💰 Tomorrow I’ll be watching $SPY & $SPX for some 0dte setups. As many Swings from last month have hit their targets I’ll be looking to add new monthly positions on $JNJ $JPM & $PLTR as all will be creating New weekly and monthly LZI zones. I’ll keep you all updated with my exact entries and exits. Goodnight all ❤️ 💤
0 · Reply
Suite510
Suite510 Sep. 12 at 2:51 AM
$JNJ $KVUE Cramer pumping the crap out of JNJ again lol 😂 like selling junk science theories
0 · Reply
ChelsArnold
ChelsArnold Sep. 11 at 7:13 PM
$JNJ NXXT base-under-base just below 2.00 is the fuel, closing push is the spark
0 · Reply
ddgcabd
ddgcabd Sep. 11 at 1:26 PM
$IMNN $LLY $AZN $JNJ As soon as you come to grips with the fact that celsion doesn't give a single shit about cancer, everything they do starts to make perfect sense.
0 · Reply
ConcernedCitizen23
ConcernedCitizen23 Sep. 11 at 11:46 AM
$IMNN I’ve posted about this before but check on your own. They are doing a “look again” phase 2 at Sloan Kettering, Johns Hopkins and MD Anderson for tissue proof of concept where they will rebiopsy the women after treatment. The CEO alluded to that research coming out within a year. Also the women who go to those places have sons and husbands in Hedge Funds. Imagine hearing your mother survived cancer due to $IMNN ! The money spigot will open big! $LLY $AZN $JNJ
0 · Reply